Introduction {#s0001}
============

It is high time since the emergence and spread of Coronavirus (COVID-19) from Wuhan, China has gained much attention without any prophylactic or therapeutic treatment as of now (Huang et al., [@CIT0019]). The situation has already taken a pandemic form with new cases even after the closing of all the air routes for travelers returning to their native land from China and other countries (World Health Organization (WHO)), 2020). As on date, a total number of cases crossed is approximately. 4.03 million from 195 countries with 278 892 deaths. There are no specific therapeutic agents or vaccines which are available for COVID-19 (WHO, [@CIT0052]). There are various drugs such as Favipiravir and Remdesivir along with Convalescent plasma are under investigation but antiviral activity on COVID-19 for these drugs is yet to be confirmed (Chen et al., [@CIT0006]; Enayatkhani et al., [@CIT0013]; Joshi et al., [@CIT0022]; Shen et al., [@CIT0040]; Wahedi et al., [@CIT0048]). Therefore finding a potent and effective anti-COVID-19 agent to control and prevent further infection has become the need of an hour. Several computational methods (Elfiky, 2020; Elfiky, 2020; Elmezayen et al., [@CIT0012]; Enmozhi et al., [@CIT0014]; Islam et al., [@CIT0020]; Muralidharan et al., [@CIT0031], Sinha et al., [@CIT0042]) have been put forward that could decipher the possible mechanism for COVID-19 treatment (Boopathi et al., [@CIT0005]; Khan et al., [@CIT0023]) through drug repositioning targeting at the various active sites of SARS-CoV-2. These targets sites are including protease, (Joshi et al., [@CIT0022]) different enzymes (Gupta et al., [@CIT0016]; Khan et al., [@CIT0023]), protein terminals, (Sarma et al., [@CIT0039]) proteins including various polymerase (Elfiky & Azzam, [@CIT0010]) and small peptides (Pant et al., [@CIT0035]) can be a good option. Probiotics are living organism with health-promoting benefits when consumed adequate amount either in the form of diet or drugs (Novik & Savich, [@CIT0034]), is beneficial for health. Lactobacillus bacterial species plays a vital role in the treatment of gastrointestinal disorder and are known to possess antibacterial (Di Cerbo et al., [@CIT0007]) and anti-viral (Sunmola et al., [@CIT0043]) properties. Inhibition of H1N1, HIV, Gastric Corona and Rotavirus *in vitro* along with a marked reduction in viral (Hasan et al., [@CIT0018]) load in vivo is well established and documented (Al Kassaa, [@CIT0002]; Ismail, [@CIT0021]). Various metabolites of Lactobacillus plantarumsecretes such as Plantaricin, lactic acid, acetic acid, and gamma-aminobutyric acid can enhance the antiviral immunity (Albarracin et al., [@CIT0003]). In order to infect any host, receptor recognition is the first step by a virus and is a critical aspect of the host cell and tissue tropism. Lie et al. in 2005 gave the concept of binding affinity between SARS-CoV and hACE2 that can correlate the viral transmissibility and disease intensity in humans (Li et al., [@CIT0025]). COVID-19 entry in a host cell is mediated by transmembrane spike (S) glycoprotein forming homotrimers expressed from a viral surface (Tortorici & Veesler, [@CIT0044]; Wan et al., [@CIT0050]). S glycoprotein binds with high affinity to Angiotensin-Converting Enzyme 2 (ACE2) receptor in humans (Walls et al., [@CIT0049]). We targeted both spike (S) glycoprotein through blocking of Residual binding domain (RBD) and ACE2 by Plantaricin group of probiotic metabolites to establish the molecular, computational role in inhibiting the entry of COVID-19 by these two mechanisms followed by blocking the RNA dependent RNA polymerase (RdDp) for the virus which might get the entry into the alveolar cell. We selected four metabolic products of *Lactobacillus plantarum* from Plantaricin category viz., Plantaricin BN, Plantaricin JLA-9, Plantaricin W, Plantaricin D to designed computer-based antiviral computational product for COVID-19 that can be consumed as probiotics to retard, inhibit and kill COVID-19 in humans either by blocking or inactivation of RdRp preventing the rise of newly budded progeny virus or by blocking RBD of S protein or interfering with ACE2 receptor proteins and could be useful in the treatment of COVID-19 until some better option is available.

Methods {#s0002}
=======

Protein modelling and quality score {#s0003}
-----------------------------------

The three-dimensional structure of the SARS-CoV-2 RNA-dependent-RNA polymerase (RdRp) enzyme was built by the Swiss-Model server. Angiotensin-converting enzyme 2 (ACE2) receptor (6VW1) and SARS-CoV-2 spike protein model (6VSB) structures were obtained from the RCSB PDB database (Berman et al., [@CIT0004]). Ramachandran plots (Furnham et al., [@CIT0015]) used to assess generated model quality parameters.

Ligands preparation {#s0004}
-------------------

Four Plantaricin compounds (Plantaricin BN CID:380907, Plantaricin JLA-9 CID_132535900, Plantaricin D CID_139586697, and Plantaricin W CID_139586573) were obtained from PubChem. Compounds energy minimizedand prepared for docking by using Molecular Operating Environment (MOE) software (MOE, 2018).

Docking {#s0005}
-------

Prior docking proteins 3D structure subjected to energy minimization, atoms partially charged and protonated using MOE. Docking software default parameters were used to find the best fit poses in the protein cavities. Chimera software will be used for visualization and calculations of ligands and protein interaction and estimation of H-bonds distances.

Ligand protein interaction and generation of images were rendered using Discovery studio,(Visualizer, [@CIT0046]) the UCSF Chimera package, (Pettersen et al., [@CIT0036]) and PLIP webserver (Salentin et al., [@CIT0038]). Compounds with docking energy ≤ −6.5** **kcal/mol are considered auspicious and proceeded for further analysis (Neira et al., [@CIT0032]).

Molecular dynamics simulations {#s0006}
------------------------------

By using of Groningen Machine for Chemicals Simulations (GROMACS) 5.1.5 package, time-dependent molecular (MD) simulation was carried out for protein-ligand complexes. Molecules scored the best docking results (plantaricin w) were selected for MD simulation. A water solvation step was carried out by AMBER 18 package, as described by Wang et al. ([@CIT0051]) (Wang et al., [@CIT0051]). System charges was then neutralized by addition of ions, then the energy minimization step was carried out (nsteps = 50,000) using the steepest descent approach (1,000 ps) with maximum force \< 1000.0 kJ/mol/nm. Particle Mesh Ewald (PME) method was employed for calculation of electrostatic interaction, then by using of leap-frog integrator system was equilibrated at time step of 2 fs (nsteps= 50,000) using a constant number, pressure and temperature (NPT), and a constant number, volume and temperature (NVT) ensembles. Molecular dynamic simulation finally runs into 10 ns, time step 0.002ps, and 5000,000 steps. Xmgarce (Turner, [@CIT0045]) was used for visualization of the graphs of Root Mean Square Deviation (RMSD) relative to the structure present in the minimized, equilibrated system (Lu et al., [@CIT0026]).

Results and discussion {#s0007}
======================

Molecular docking results {#s0008}
-------------------------

Three compounds (Plantaricin W, Plantaricin JLA-9, and Plantaricin D) significantly interacted with RdRp, RBD, and ACE2, scoring the lowest binding energy (≤−6.5 kcal/mol) ([Table 1](#t0001){ref-type="table"}). Antiviral activity of Lactobacillus plantarum probiotics bacteria has been documented previously on the influenza virus, (Rodrigo-Torres et al., [@CIT0037]) supports our finding.

###### 

Docking scores and PubChem CIDs of the four Plantaricin compounds.

  Molecule            PubChem CID   RdRp    RBD    ACE2                  
  ------------------- ------------- ------- ------ ------- ----- ------- ------
  Plantaricin W       139586573     −14.7   3.87   −11.1   2.5   −12.7   4.3
  Plantaricin JLA-9   132535900     −11.4   4.1    −8.0    1.3   −9.1    2.6
  Plantaricin D       139586697     −10.1   1.9    −8.6    1.9   −8.5    3.2
  Plantaricin BN      380907        −6.4    1.8    −5.4    2.2   −6.0    1.47

Molecular docking of RdRp {#s0009}
-------------------------

Plantaricin W, D, and JLA-9 are able to bind RdRp tightly, with binding energies of −14.7, −11.4, and −10.1ACE2, respectively. The following residues in RpRp active site showed different types of interactions as shown in [Table 2](#t0002){ref-type="table"}: GLU167, PRO169, HIS439, ASP452, TYR455, TYR456, ARG457, ASN497, LYS500, ALA550, LYS551, ARG553, THR556, ALA558, ARG569, TYR619, LYS621, ASP623, ARG624, THR680, SER682, ASP684, ALA688, ASN760, ALA797, and LYS798. These three compounds were able to block the residues (THR556, ALA558) surrounding the deep grove catalytic site (VAL557) of RdRp (Lung et al., [@CIT0027]).

###### 

Interaction of compounds with RdRp, RBD and ACE2.

  Molecule                   PubChem ID                     RdRp   RBD   ACE2                                    
  -------------------------- ------------- ---------------- ------ ----- ------ ------ ----- ------ ------ ----- ------
  Plantaricin W              139586573     Hydrogen Bonds   167    GLU   2.26   345    THR   2.74   26     LYS   2.79
  439                        HIS           2.72             345    THR   3.28   33     ASN   3.7                 
  456                        TYR           2.32             347    PHE   2.2    37     GLU   1.95                
  456                        TYR           2.05             441    LEU   2.6    90     ASN   2.7                 
  457                        ARG           2.87             446    GLY   3.14   90     ASN   2.81                
  550                        ALA           2.38             446    GLY   3.2    319    GLY   2.54                
  551                        LYS           2.17             446    GLY   2.3    353    LYS   2.9                 
  553                        ARG           2.96             451    TYR   2.58   354    GLY   2.63                
  553                        ARG           2.34                                 383    MET   2.28                
  621                        LYS           1.9                                  393    ARG   2.47                
  623                        ASP           3.45                                 548    THR   2.61                
  624                        ARG           2.62                                 26     LYS   2.79                
  624                        ARG           1.96                                 33     ASN   3.7                 
  682                        SER           2.27                                                                  
  691                        ASN           2.58                                                                  
  760                        ASP           2.9                                                                   
  797                        ALA           2.74                                                                  
  798                        LYS           2.67                                                                  
  Hydrophobic Interactions   169           PRO              3.77   446   GLY    3.99   29    LEU    3.41         
  555                        ARG           3.94             447    GLY   3.95   321    PRO   3.81                
  558                        ALA           3.9                                  386    ALA   3.91                
                                                                                389    PRO   3.89                
                                                                                555    PHE   3.74                
  Salt Bridges               623           ASP              4.07                       37    GLU    3.86         
  760                        ASP           3.87                                                                  
  Plantaricin JLA-9          132535900     Hydrogen Bonds   452    ASP   2.05   446    GLY   3.5    26     LYS   3.07
  452                        ASP           2.3              494    SER   2.1    30     ASP   1.89                
  497                        ASN           2.29             351    TYR   2.59   92     THR   2.75                
  500                        LYS           2.24             491    GLN   3.50   96     GLN   2.27                
  553                        ARG           2.14                                 352    GLY   2.9                 
  556                        THR           2.51                                 352    GLY   3.03                
  619                        TYR           2.6                                  353    LYS   3.07                
  621                        LYS           3.08                                 354    GLY   2.32                
  623                        ASP           2.3                                  355    ASP   2.91                
  624                        ARG           2.56                                 387    ALA   2.19                
  680                        THR           2.83                                 388    GLN   2.37                
  682                        SER           2.05                                                                  
  682                        SER           2.83                                                                  
  688                        ALA           2.6                                                                   
  Hydrophobic Interactions   455           TYR              3.78   451   TYR    3.60   26    LYS    3.73         
  455                        TYR           3.47             351    TYR   2.95                                    
  553                        ARG           3.59                                                                  
  623                        ASP           3.5                                                                   
  Salt Bridges               500           LYS              3.36                                                 
  569                        ARG           5.01                                                                  
  π-Cation Interactions      798           LYS              5.19                       26    LYS    3.32         
  Plantaricin D              139586697     Hydrogen Bonds   500    LYS   3.74   415    THR   3.23   96     GLN   2.45
  553                        ARG           2.44             449    TYR   2.1    350    ASP   2.66                
  621                        LYS           2.83             453    TYR   2.71   353    LYS   2.47                
  682                        SER           3.11             496    GLY   3.13   354    GLY   3.07                
  684                        ASP           2.27                                 383    MET   2.34                
  688                        ALA           2.86                                 393    ARG   3.49                
  760                        ASP           2.27                                                                  
  Hydrophobic Interactions   455           TYR              3.75   403   ARG    3.52   386   ALA    3.73         
  455                        TYR           3.5              421    TYR   3.72                                    
  624                        ARG           3.77             505    TYR   3.62                                    

Plantaricin Winteracted with RdRp active site residues by 18 hydrogen bonds with RdRp enzyme with mean distance 2.7** **Å and three hydrophobic bonds, which contribute significantly in binding ([Table 2](#t0002){ref-type="table"}) ([Figures 1, 2, and 3](#F0001 F0002 F0003){ref-type="fig"}). The activity of Plantaricins W, d, and JLA-9 on catalytic site of RdRp is better than the activity of other molecules on RdRp: Lung and his colleagues found thataflavin interacts with RdRp with energy −9.11 (Lung et al., [@CIT0027]), and (Elfiky, 2020) found IDX-184 interact with binding energy −9.3 to RdRp enzyme.

![Three-dimensional structure of RNA-dependent-RNA polymerase (RdRp) enzymes with Plantaricin W blocking the active site cavity.](TBSD_A_1775123_F0001_C){#F0001}

![Interaction of Plantaricin D and RNA-dependent-RNA polymerase(RdRp) enzymes. (A) The three-dimensional structure of ligand is surrounded d by the hydrophobic surface of RdRp. (B) Two-dimensional interaction shows hydrogen bonds in green dotted lines.](TBSD_A_1775123_F0002_C){#F0002}

![Interaction of Plantaricin JLA and RNA-dependent-RNA polymerase (RdRp) enzymes. (A) The three-dimensional structure of ligand is surrounded d by the hydrophobic surface of RdRp. (B) Two-dimensional interaction shows hydrogen bonds in green dotted lines.](TBSD_A_1775123_F0003_C){#F0003}

Molecular docking of RBD {#s0010}
------------------------

We investigated the potential activity of the four Plantaricinpeptides against RBD of SARS-CoV-2. Plantaricin W, Plantaricin D, and Plantaricin JLA-9 exhibited a strong docking affinity to the RBD, with binding energies −11.1, −8.6, and −8.0** **Å respectively ([Table 1](#t0001){ref-type="table"}). They formed different hydrogen, hydrophobic, and salt bridges bonds with the following residues of RBD THR345, PHE347, TYR351, ARG403, THR415, TYR421, LEU441, GLY446, GLY447, TYR449, TYR451, TYR453, GLN491, SER494, GLY496and TYR505 as presented in [Table 2](#t0002){ref-type="table"}. These compounds showed strong hydrogen bonds with key residues (GLY446, TYR449, and TYR453) of RBD, that have a role in ACE2 binding (Yan, Zhang, Guo, et al., [@CIT0053]; Yan, Zhang, Li, et al., [@CIT0054]) ([Figure 4, 5, and 6](#F0004 F0005 F0006){ref-type="fig"}).

![Interaction of Plantaricin JLA and SARS-CoV-2 receptor-binding domain (RBD). (A) The three-dimensional structure of ligand and amino acids, the RBD is coloured white. (B) Two-dimensional interaction shows hydrogen bonds in green dotted lines. (C) Two-dimensional structure and PubChem ID of Plantaricin JLA ligand.](TBSD_A_1775123_F0004_C){#F0004}

![Interaction of Plantaricin D and SARS-CoV-2 receptor-binding domain (RBD). (A) The three-dimensional structure of ligand and amino acids, the RBD is coloured white. (B) Two-dimensional interaction shows hydrogen bonds in green dotted lines. (C) Two-dimensional structure and PubChem ID of Plantaricin D ligand.](TBSD_A_1775123_F0005_C){#F0005}

![Interaction of Plantaricin W and SARS-CoV-2 receptor-binding domain (RBD). (A) The three-dimensional structure of ligand and amino acids, the RBD is coloured white. (B) Two-dimensional interaction shows hydrogen bonds in green dotted lines. (C) Two-dimensional structure and PubChem ID of Plantaricin W ligand.](TBSD_A_1775123_F0006_C){#F0006}

Molecular docking of ACE2 {#s0011}
-------------------------

Many published studies suggested that the blocking of viral attachment site in the ACE2 receptor could be useful for patients with COVID-19 (Gurwitz, [@CIT0017]). In this study, three peptides: Plantaricin W, Plantaricin JLA-9, Plantaricin D showed significant activity on human ACE2 receptor, with binding energies −12.7, −9.1, and -8.5** **Å respectively ([Table 1](#t0001){ref-type="table"}). The following residues involving in the interaction with ACE2 receptor:LYS26, LEU29, ASP30, ASN33, GLU37, ASN90, THR92, GLN96, GLY319, PRO321, ASP350, GLY352, LYS353, GLY354, MET383, ALA386, ALA387, GLN388, ARG393, THR548, and PHE555 ([Table 2](#t0002){ref-type="table"}).Plantaricin JLA-9 form strong hydrogen bond (with distance 1.89** **Å) with ASP30, and Plantaricin W forms another hydrogen bond (2.9** **Å) with LYS353 key residues in interaction with RBD of SARS-CoV-2 (Yan, Zhang, Guo, et al., [@CIT0053]; Yan, Zhang, Li, et al., [@CIT0054]) ([Figures 7, 8, and 9](#F0007 F0008 F0009){ref-type="fig"}).

![Interaction of Plantaricin W and angiotensin-converting enzyme 2 (ACE2) receptor. (A) The three-dimensional structure of ligand is surrounded d by the hydrophobic surface of ACE2. (B) Two-dimensional interaction shows hydrogen bonds in green dotted lines.](TBSD_A_1775123_F0007_C){#F0007}

![Interaction of Plantaricin JLA-9 and angiotensin-converting enzyme 2 (ACE2) receptor. (A) The three-dimensional structure of ligand is surrounded d by the hydrophobic surface of ACE2 (B) Two-dimensional interaction shows hydrogen bonds in green dotted lines.](TBSD_A_1775123_F0008_C){#F0008}

![Interaction of Plantaricin D and angiotensin-converting enzyme 2 (ACE2) receptor. (A) The three-dimensional structure of ligand is surrounded d by the hydrophobic surface of ACE2. (B) Two-dimensional interaction shows hydrogen bonds in green dotted lines.](TBSD_A_1775123_F0009_C){#F0009}

Lactobacilli species produce hydrogen peroxide, acides, biosurfactants and bacteriocins giving sufficient protection to host cell (La Fata et al., [@CIT0024]; Mousavi Khaneghah et al., [@CIT0030]). Several lactic acid bacteria can synthesize Exopolyscacharides that can modulate the health benefits such as antitumor, antibiofilm and antioxidant activity along with immunomodulatory effects (Silva et al., [@CIT0041]) such as interference of HIV attachment to target host cells (Martenot et al., [@CIT0029]).

Lactobacillus plantarum metabolic products established earlier as antiviral metabolites 8 is now computationally proved to inhibit the COVID-19 at various levels. Assessment of our results on COVID-19 through computational studies provides a better glimpse of inhibition, there may be other mechanisms by which these plant products might be working on COVID-19 that need to be deciphered for experiments. Further, these metabolites may also be involved in indirect stimulation of innate and other immunity. Our study can be used as one of the anti-COVID-19 mechanistic approaches through probiotic intake until some effective treatment or vaccine is developed.

Molecular dynamic simulations {#s0012}
-----------------------------

The molecular dynamic simulation was used to check the stability of the complexes of plantaricin w and SARS-CoV-2 RdRp enzyme, RBD of spike protein, and human ACE2 receptor. Root-mean-square deviation (RMSD) of the protein backbones was calculated to study the stability of complexes over a period of time. From RMSD trajectories, as shown in [Figure 10](#F0010){ref-type="fig"}, all complexes scored values ranged from 1** **nm to 3** **nm, indicating their high stability. RdRP and ACE2 complexes showed RMSD level near to 0.1** **nm (1** **Å) after a short period of time (0.1** **ns) indicating their best stability (Vyas et al., [@CIT0047]), this finding agrees with that they have scored the best docking energies (−14.7, and −12.7 respectively) stating their strong interaction.

![RMSD plot of RBD, RdRp, and ACE2 proteins backbones in complex with plantaricin w, over one nanosecond period.](TBSD_A_1775123_F0010_C){#F0010}

Conclusion {#s0013}
==========

The present computational representation and molecular dynamics study clearly demonstrates the antiviral activity (Aanouz et al., [@CIT0001]) of Plantiricin compounds, through multiple mechanistic approach by metabolic product of *Lactobacillus plantarum* blocks the entry by binding with RdRp, RBD, and ACE2. The blocking of main structural protein S is one of the essential accessory protien, playing a vital role in the life cycle of SARS-CoV-2 can prove to be one of the best target for other molecules. The claim is substantiated by Molecular dynamics model that further strengthen stability of the complexes of plantaricin w and SARS-CoV-2 RdRp enzyme, RBD of spike protein, and human ACE2 receptor. Molecular dynamics and computational model are the tools that can precisely predict to reposition the drugs without going in the clinical phase for the effective treatment of COVID-19. Further, it is difficult to find the drug that has a better safety profile than these macrolides, with a cheaper cost, which can be linked with the clinical data for further studies. The present study can state that best possible way about these metabolites that can cease the infection if taken under proper medical supervision. The three antibiotics Azithromycin, Clarithromycin and Erythromycin can be used against new strain of coronavirus with promising result with three way specific target against COVID-19. As of now the plantaricin metabolites can be the alternate till new antiviral drug specific for COVID-19 is discovered.
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